Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTITHROMBIN III HUMAN for Thrombosis prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ANTITHROMBIN III HUMAN was used for Thrombosis prophylaxis.

Most Reported Side Effects for ANTITHROMBIN III HUMAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 19 20.7% 5 12
Off label use 17 18.5% 1 4
Contraindicated product administered 11 12.0% 1 0
Prescribed overdose 11 12.0% 1 0
Foetal exposure during pregnancy 9 9.8% 1 0
Hepatic function abnormal 7 7.6% 0 7
Hyperglycaemia 7 7.6% 0 7
Premature baby 7 7.6% 0 0
Adenovirus infection 5 5.4% 0 5
Cholestasis 5 5.4% 0 5
Diarrhoea 5 5.4% 0 5
Graft versus host disease 5 5.4% 0 5
Ileus paralytic 5 5.4% 0 5
Low birth weight baby 5 5.4% 0 1
Maternal exposure during pregnancy 5 5.4% 0 3

Other Indications for ANTITHROMBIN III HUMAN

Prophylaxis (14) Anticoagulant therapy (12) Antithrombin iii deficiency (9) Product used for unknown indication (6) Abnormal clotting factor (5) Foetal exposure during pregnancy (5)

Other Drugs Used for Thrombosis prophylaxis

RIVAROXABAN (27,466) APIXABAN (4,304) ENOXAPARIN (4,166) ASPIRIN (2,442) HEPARIN (1,633) CLOPIDOGREL BISULFATE (1,529) DABIGATRAN ETEXILATE (1,113) WARFARIN (959) TICAGRELOR (524) DALTEPARIN (519)

Related Pages

ANTITHROMBIN III HUMAN Full Profile All Thrombosis prophylaxis Drugs ANTITHROMBIN III HUMAN Demographics ANTITHROMBIN III HUMAN Timeline